Industry Resources | June 22, 2020
Establishing Minimum Standards In Medicaid State Drug Utilization Review & Supporting Value-Based Purchasing For Drugs Covered In Medicaid, Revising Medicaid Drug Rebate & Third Party Liability Requirements
The Centers for Medicare & Medicaid Services (CMS) published the notice of proposed rulemaking on June 19, 2020, in the Federal Register. Among its provisions, the proposed rule makes changes to the Medicaid Drug Rebate Program to support value-based purchasing arrangements between state Medicaid programs and drug manufacturers. It also establishes a minimum standard for state Medicaid drug utilization review of opioid prescriptions . . .